胸骨抬举法辅助经剑突下胸腔镜微创手术治疗胸腺病变的初步尝试  

Primary experience of subxiphoid thoracoscopic approach for minimally invasive thymectomy assisted by sternum-elevating technique

作　　者：汪灏[1] 李继军[1,2] 丁建勇[1] 金淳[1] 张永星[1] 谭黎杰[1] 葛棣[1] 王群[1] 

机构地区：[1]复旦大学附属中山医院胸外科,上海200032 [2]喀什地区第二人民医院心胸外科,喀什844000

出　　处：《中国临床医学》2017年第2期188-190,共3页Chinese Journal of Clinical Medicine

摘　　要：目的:探讨胸骨抬举法辅助经剑突下胸腔镜微创手术治疗胸腺病变的临床疗效。方法:2016年3月至2016年7月对连续24例胸腺病变患者采用经剑突下胸腔镜微创切除术,其中后12例加用术中胸骨抬举法辅助(研究组)。比较两组患者围手术期相关临床指标。结果:研究组患者手术时间少于对照组[(80.3±14.9)min vs(96.2±17.3)min],差异有统计学意义(P<0.01)。两组患者在出血量、中转开胸率、并发症、术后住院时间和术后疼痛评分方面差异无统计学意义。结论:胸骨抬举法辅助经剑突下胸腔镜治疗胸腺疾病简便经济、安全可靠、疗效满意,值得临床推广。Objective：To discuss the clinical efficacy of subxiphoid thoracoscopic approaches for minimally invasive thymectomy assisted by sternum-elevating technique.Methods：From March 2016 to July 2016,24 consecutive patients with thymic mass underwent thoracoscopic extended thymectomy via subxiphoid approach.For the later 12cases（study group）,the sternum-elevating technique was used additionally.The perioperative outcomes of two groups were compared.Results：The patients in study group had much shorter surgical duration（[80.3±14.9]min vs[96.2±17.3]min,P0.01）than control group.However,no significant difference was found on the other outcomes between the two groups,including blood loss,conversion to open surgery,morbidities,postoperative hospital stay and patient＇s pain scores.Conclusions：The subxiphoid thoracoscopic approach for minimally invasive thymectomy assisted by sternal elevating is simple and cost-effective,safe and effective.It is a promising approach for clinical expansion.

关 键 词：胸骨抬举法 经剑突下胸腔镜微创手术 胸腺切除术 

分 类 号：R583[医药卫生—内分泌]